Executive Summary
This digest of 50 SEC filings from August 19, 2026, reveals a market sharply bifurcated between distressed situations and strategic M&A. A cluster of 10 SPAC filings, including a $200 million IPO (Karman Line) and several delistings (Artius II, Xos warrants), highlights the ongoing churn in the blank-check sector.
The most critical developments are the near-completion of the $77/share acquisition of Forte Biosciences by argenx, a high-risk delisting notice for Skye Bioscience, and a massive $1.0 billion token deal for Flora Growth Corp. On the distressed side, three Indian companies (AGS Transact, Setubandhan, Zicom) are in active insolvency, while two iShares ETFs were voluntarily liquidated. Insider activity is notably absent across the filings, but forward-looking data points to several key catalysts, including shareholder votes and compliance deadlines. The overarching theme is capital allocation under pressure: companies are either aggressively pursuing transformative M&A, winding down, or fighting for survival.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: DEFM14A · 8-K · Schedule 13D
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from August 18, 2026.
Investment Signals (10)
- Forte Biosciences ↓ (BULLISH)▲
HSR Act waiting period expired for argenx's $77/share tender offer, clearing a key antitrust hurdle and moving the acquisition closer to completion. This is a near-certain cash-out event for shareholders.
- Skye Bioscience ↓ (BEARISH)▲
Received a Nasdaq delisting notice due to negative stockholders' equity (-$497K vs $2.5M minimum). The stock faces imminent suspension unless a compliance plan is accepted by Oct 2, 2026.
- Flora Growth Corp ↓ (MIXED)▲
Announced a transformative deal to receive $1.0B in Memecore tokens for shares and warrants at a 12x premium to market price. While highly speculative, the deal could dramatically increase the company's strategic value in decentralized AI.
- Refex Renewables ↓ (BULLISH)▲
Withdrawal of CIRP against its subsidiary Sherisha Solar following a settlement removes a significant legal overhang, signaling a positive resolution to a distressed situation.
- Datavault AI ↓ (MIXED)▲
Completed the acquisition of NYIAX, adding blockchain settlement infrastructure and patents. The deal supports a $200M revenue target for FY2026, but integration risks and lack of financial details warrant caution.
- OSR Holdings ↓ (BEARISH)▲
Received a final delisting notice from Nasdaq for failing to maintain the $1.00 bid price. Trading will be suspended on Aug 26, 2026, with no stay available, making this a high-risk delisting event.
- Genpact ↓ (NEUTRAL)▲
Filed S-4 to reincorporate from Bermuda to Delaware, a move that often signals a potential future tax restructuring or M&A activity. The change is expected to be effective March 1, 2027.
- Mereo BioPharma ↓ (BEARISH)▲
Granted a second 180-day extension until Feb 16, 2027, to regain compliance with Nasdaq's $1.00 bid price rule. Failure to do so will trigger delisting proceedings.
- AGS Transact Technologies ↓ (BEARISH)▲
The 16th CoC meeting scheduled for Aug 21, 2026, indicates ongoing but stalled insolvency proceedings. The lack of a resolution plan after multiple meetings is a negative signal for recovery.
- Zicom Electronic Security Systems ↓ (BEARISH)▲
Filed audited FY2022-23 results with an adverse audit opinion, nearly 40 months late. This highlights severe operational and governance failures under CIRP.
Risk Flags (9)
- Skye Bioscience/Delisting↓ [HIGH RISK]▼
Stockholders' equity is negative (-$497K), failing the $2.5M minimum. The company has 45 days to submit a compliance plan; failure leads to delisting.
- OSR Holdings/Delisting↓ [HIGH RISK]▼
Nasdaq will suspend trading on Aug 26, 2026, due to bid price non-compliance. The company cannot stay the suspension as it already used a second compliance period.
- Artius II Acquisition/Delisting↓ [HIGH RISK]▼
Filed Form 25-NSE to delist from Nasdaq, typical of a SPAC winding down without a business combination. Shareholders face liquidation risk.
- Zicom Electronic Security Systems/Insolvency↓ [HIGH RISK]▼
Adverse audit opinion for FY2022-23 due to material discrepancies in assets and inventories. The company has been under CIRP since July 2022 with no resolution.
- Setubandhan Infrastructure/Insolvency↓ [HIGH RISK]▼
Cannot submit financial results due to missing records. Resolution plan was rejected by NCLT in March 2025, and an appeal is pending.
- AGS Transact Technologies/Insolvency↓ [MEDIUM RISK]▼
16th CoC meeting scheduled, but the company has been under CIRP without a clear resolution path. The prolonged process increases the risk of liquidation.
- Mereo BioPharma/Delisting↓ [MEDIUM RISK]▼
Second bid price non-compliance notice. If the stock does not close above $1.00 for 10 consecutive days by Feb 16, 2027, delisting is likely.
- 3i Infotech/Fraud Investigation↓ [MEDIUM RISK]▼
A preliminary inquiry by the Economic Offence Wing found the matter 'civil in nature,' but the complaint involves over ₹128 Crore. The financial impact remains unascertained.
- Xos, Inc./Delisting↓ [MEDIUM RISK]▼
Nasdaq delisted the company's warrants (XOSWW) effective Aug 19, 2026, under Rule 12d2-2(a)(2). While the common stock remains listed, the warrant delisting is a negative signal.
Opportunities (8)
- Forte Biosciences/Merger Arbitrage↓ (OPPORTUNITY)◆
The HSR waiting period has expired, clearing the way for argenx's $77/share tender offer. With the deal moving to close, this offers a near-risk-free arbitrage opportunity for the remaining spread.
- Refex Renewables/Legal Resolution↓ (OPPORTUNITY)◆
The withdrawal of CIRP against its subsidiary removes a major legal overhang. This could unlock value in the subsidiary and improve the parent company's financial outlook.
- Flora Growth Corp/Strategic Pivot↓ (SPECULATIVE OPPORTUNITY)◆
The $1.0B token deal with Puple AI could transform the company into a major player in decentralized AI. If the warrants are approved and the token value holds, the upside is substantial.
- Earth Science Tech/Margin Expansion↓ (OPPORTUNITY)◆
The acquisition of Zoolzy LLC provides internal access to APIs, which should drive margin expansion for its compounding pharmacies. The entry into the veterinary market is a new growth vector.
- Karman Line Acquisition Corp/SPAC IPO↓ (OPPORTUNITY)◆
The $200M SPAC IPO targeting aerospace and defense provides a clean, liquid vehicle for investors to gain exposure to the sector. The focus on space-based infrastructure is a thematic tailwind.
- Genpact/Reincorporation↓ (OPPORTUNITY)◆
The move to Delaware could be a precursor to a more favorable tax structure or future M&A. The stock is a stable, large-cap play on business process outsourcing.
- Cipla Limited/Operational Efficiency↓ (OPPORTUNITY)◆
The NCLT-approved amalgamation of its WOS Inzpera Healthsciences is expected to achieve cost savings and improve organizational efficiency, with no new shares issued.
- Pasupati Fincap/Open Offer↓ (OPPORTUNITY)◆
Uday Narang's open offer at ₹12/share provides a clear exit for shareholders at a fixed price. The tendering period runs from Sept 29 to Oct 13, 2026.
Sector Themes (5)
- SPAC Sector Churn◆
10 filings involve SPACs, ranging from a $200M IPO (Karman Line) to delistings (Artius II) and routine governance updates. The sector is seeing a bifurcation between well-capitalized new issuers and those failing to find targets.
- Indian Insolvency Wave◆
Three Indian companies (AGS Transact, Setubandhan, Zicom) are in active CIRP, with Zicom's 40-month late filing and adverse audit opinion highlighting severe governance failures. This cluster suggests systemic stress in certain Indian industrial sectors.
- Biotech Distress and M&A◆
Forte Biosciences is being acquired at a premium, while Skye Bioscience and Mereo BioPharma face delisting. This bifurcation shows that while quality assets attract buyers, cash-poor biotechs are at high risk of being forced out of public markets.
- Renewable Energy Infrastructure Build-out◆
Multiple filings (Ceigall India, Enviro Infra, Nitin Spinners, Torrent Power, Phoenix Mills) show capital flowing into renewable energy SPVs and project companies. This is a long-term thematic trend of corporate investment in green energy.
- Liquidation of ESG Thematic ETFs◆
iShares Trust voluntarily delisted and liquidated two ESG Aware allocation ETFs (EAOA, EAOR). This suggests a potential shift in investor demand away from thematic ESG products or a portfolio rationalization by BlackRock.
Watch List (8)
-
Must submit a Nasdaq compliance plan by Oct 2, 2026. Watch for the plan's details, especially regarding the concurrent Redx Pharma acquisition. [Date: Oct 2, 2026]
-
Tender offer is moving to close. Monitor for final acceptance and payment of $77/share. [Date: Imminent]
-
Trading will be suspended on Aug 26, 2026. Watch for any last-minute appeal or alternative listing venue. [Date: Aug 26, 2026]
-
Has until Feb 16, 2027, to regain bid price compliance. Monitor stock price for any recovery or reverse split announcement. [Date: Feb 16, 2027]
-
16th CoC meeting on Aug 21, 2026. Watch for any resolution plan updates or liquidation recommendations. [Date: Aug 21, 2026]
-
Shareholder approval for the warrant issuance is required under Nasdaq rules. Monitor for the special meeting date and outcome. [Date: TBD]
-
Open offer tendering period runs from Sept 29 to Oct 13, 2026. Monitor for any competing offers or changes in share price. [Date: Sept 29, 2026]
- 👁
Special general meeting to approve the Delaware reincorporation. Monitor for the meeting date and any shareholder dissent. [Date: TBD, before March 1, 2027]
Filing Analyses
(50)
19-08-2026
Columbus Acquisition Corp (CAC) is seeking shareholder approval at an Extraordinary General Meeting on September 10, 2026, for a business combination with WISeSat.Space Corp. (d/b/a SpaceAIQ Corp.) via a share exchange and merger with Pubco WISeSat.Space Holdings Corp. The combined entity will list on Nasdaq under the symbol 'SAIQ'. The deal includes a $10 million PIPE investment from SEALSQ Corp, but the proxy statement does not disclose CAC's current cash position or redemption levels, leaving uncertainty about post-merger cash available.
- · The Business Combination Agreement was originally dated November 9, 2025, and amended on August 6, 2026.
- · CAC's units, ordinary shares, and rights are currently listed on Nasdaq under symbols COLAU, COLA, and COLAR, respectively, and will cease trading upon closing.
- · The PIPE Investor (SEALSQ) is an affiliate and shareholder of the Company.
- · The PIPE Subscription Agreement includes a price adjustment mechanism: if the 10-day VWAP 60 days after closing is below the PIPE Purchase Price, additional shares are issued (subject to a floor of $5.00 per share).
- · The NTA Proposal seeks to amend CAC's articles to remove the $5,000,001 net tangible assets redemption restriction, expanding methods to avoid penny stock rules.
- · The proxy statement/prospectus covers registration of up to 31,385,052 Pubco Ordinary Shares in connection with the Business Combination.
- · No financial performance data (revenue, EBITDA, etc.) for the Company or CAC is provided in this excerpt.
19-08-2026
Datavault AI Inc. (DVLT) completed the acquisition of NYIAX, adding institutional-grade exchange technology, blockchain settlement infrastructure, and a portfolio of four issued U.S. patents. The deal is expected to accelerate Datavault AI's tokenization pipeline and support its full-year 2026 revenue target of at least $200 million. However, the filing contains no financial details of the transaction, and integration risks remain, with no disclosed current revenue or profitability metrics for either company.
- · NYIAX was founded in 2017 and pioneered exchange-based trading of guaranteed advertising contracts.
- · NYIAX acquired Collective Audience in August 2025, adding commercialization and European presence.
- · The acquired patents cover electronic continuous trading of variant inventories (Nos. 10,607,291; 11,410,236; 11,861,707; 12,198,193).
- · NYIAX expects to recommend two representatives for consideration to Datavault AI's Board of Directors.
- · Datavault AI and NYIAX have been collaborating since March 2025 under a licensing and marketing agreement.
19-08-2026
AGS Transact Technologies Limited, currently under the Corporate Insolvency Resolution Process (CIRP), has informed the stock exchanges that the 16th meeting of the Committee of Creditors (CoC) is scheduled for August 21, 2026. The company is being managed by a Deemed Resolution Professional, Brijendra Kumar Mishra, indicating ongoing insolvency proceedings.
- · The company is under CIRP (Corporate Insolvency Resolution Process).
- · The 16th CoC meeting will be held via video conferencing.
- · The Deemed Resolution Professional is registered with IBBI (IBBI/IPA-002/IP-N00109/2017-2018/10257).
19-08-2026
Ceigall India Limited's Management Committee approved a further investment of INR 29.44 Crore in its subsidiary, Ceigall Indore Ujjain Greenfield Highway Limited (Project SPV), via equity and loans/guarantees to finance a 48.10 km highway project on Hybrid Annuity Mode. The Project SPV has minimal current turnover of Rs. 0.40 Lakh and was incorporated in January 2026, reflecting an early-stage infrastructure development initiative. The investment is a routine capital infusion for a project SPV, with no related-party concerns beyond the subsidiary relationship.
- · The Project SPV was incorporated on 15/01/2026 and has only one year of financial history (FY ended March 2026 turnover of Rs. 0.40 Lakh).
- · Ceigall India will hold 74% of the SPV equity; CIPPL (wholly-owned subsidiary) will hold 26%.
- · The investment will be made in tranches as per project fund requirements.
- · No governmental or regulatory approvals are required for the acquisition.
- · The meeting of the Management Committee lasted from 11:45 AM to 12:05 PM IST on 19th August 2026.
19-08-2026
Setubandhan Infrastructure Limited, under CIRP since November 2022, has informed stock exchanges that it cannot submit its unaudited financial results for the quarter ended June 30, 2026, due to the non-availability of financial records and books of accounts. The company's resolution plan was rejected by NCLT on March 24, 2025, and an appeal is pending before NCLAT. The Resolution Professional continues efforts to secure the records but has not yet been able to finalize financial statements.
- · CIRP application was filed by State Bank of India under Section 7 of IBC.
- · CIRP was admitted by NCLT Mumbai Bench on November 28, 2022.
- · Resolution plan was rejected by NCLT on March 24, 2025.
- · An appeal against the rejection was filed before NCLAT on July 9, 2025, and is pending.
- · The Resolution Professional's IBBI registration number is IBBI/IPA-001/IP-P00640/2017-2018/11093.
- · AFA validity of the RP is up to December 31, 2026.
19-08-2026
Nandini Modi and Kirit Modi, along with Persons Acting in Concert (PACs), have announced a mandatory open offer to acquire up to 48,75,000 equity shares (26% of voting capital) of The South India Paper Mills Limited at ₹120 per share, aggregating to ₹58,50,00,000. This follows a Share Purchase Agreement to acquire 37,90,240 shares (20.21%) from selling shareholders Harshad Natvarlal Modi and Rajul Harshad Modi for ₹45,48,28,800. The offer is triggered under SEBI (SAST) Regulations and is not contingent on minimum acceptance.
- · Open offer is mandatory under SEBI (SAST) Regulations 3(1) and 4, triggered by SPA for 20.21% stake.
- · Offer price of ₹120 per share is based on frequently traded shares on BSE.
- · Tendering period will be 10 working days, detailed in Letter of Offer.
- · No convertible securities, warrants, or locked-in shares as per June 30, 2026 shareholding pattern.
- · Acquirers and PACs will gain control and be classified as promoter/promoter group post-transaction.
19-08-2026
Enviro Infra Engineers Limited announced that its step-down subsidiary Suyog Urja Limited incorporated a wholly owned subsidiary (WOS), Wind Earth Private Limited, on August 19, 2026. The new entity is engaged in the renewable energy sector, focusing on wind power generation and related services. No financial figures or period comparisons were disclosed, as this is a routine corporate structure update.
19-08-2026
Forte Biosciences, Inc. filed Amendment No. 1 to its Schedule 14D-9, disclosing that the HSR Act waiting period for argenx BV's tender offer to acquire all outstanding shares of Forte at $77.00 per share expired on August 18, 2026. This satisfies a key condition to the offer, moving the acquisition closer to completion.
- · The HSR Act waiting period expired at 11:59 p.m., Eastern Time, on August 18, 2026.
- · The Premerger Notification and Report Form was filed with the FTC and Antitrust Division on August 3, 2026.
- · The condition set forth in clause (e)(i) of Annex I to the Merger Agreement has been satisfied.
19-08-2026
Skye Bioscience, Inc. received a Nasdaq delisting notice on August 18, 2026, because its stockholders' equity was negative ($497,307), falling short of the $2,500,000 minimum required by Listing Rule 5550(b)(1). The company has 45 days (until October 2, 2026) to submit a compliance plan; if accepted, Nasdaq may grant an extension until February 14, 2027. While the stock continues trading under 'SKYE' for now, the company faces significant risk of delisting and is concurrently pursuing the acquisition of Redx Pharma Limited.
- · The delisting notice is based on the company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
- · The company is also pursuing the acquisition of Redx Pharma Limited, which may be relevant to its compliance plan.
- · If the compliance plan is not accepted, the company has the right to appeal, and the stock would remain listed until the appeal process is completed.
- · There is no assurance that the company will be able to regain compliance or maintain compliance with other listing requirements.
19-08-2026
On August 13, 2026, Collective Acquisition Corp. (formerly Dune Acquisition Corp II) issued 3,500,000 Class A ordinary shares to its sponsor, Collective Acquisition Sponsor LLC, upon conversion of an equal number of Class B ordinary shares. No consideration was paid for the conversion, and the shares remain subject to the same restrictions as the Class B shares. Following the conversion, the company has 5,119,501 Class A ordinary shares and 2,250,000 Class B ordinary shares outstanding.
- · The conversion was exempt from registration under Section 3(a)(9) of the Securities Act.
- · The Class A shares issued are subject to transfer restrictions, waiver of redemption rights, and an obligation to vote in favor of a business combination.
- · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
19-08-2026
The Phoenix Mills Limited and its subsidiary Offbeat Developers Private Limited have been allotted equity shares and Series B Compulsory Convertible Debentures in O2 Renewable Energy XXVIII Private Limited, a renewable energy captive generating company. Post allotment, the Phoenix Mills group holds a 45.00% equity stake in O2 Renewable XXVIII. This investment is aimed at meeting captive user requirements for renewable electricity.
- · The allotment was made pursuant to an Amendment to the Security Subscription and Shareholders’ Agreement dated July 29, 2026.
- · The investment is structured to meet captive user requirements for purchase of renewable energy (electricity) from the captive generating plant.
19-08-2026
Nitin Spinners Limited acquired 95,68,162 equity shares of Rs. 10 each in CGE II Hybrid Energy Private Limited on August 19, 2026, increasing its total shareholding to 2,57,04,545 equity shares, representing 7.36% of the paid-up share capital. This acquisition aligns with the company's expansion into renewable energy generation.
- · The acquisition is a continuation of a prior intimation dated 27.03.2026.
- · CGE II Hybrid Energy Private Limited is engaged in the generation of renewable energy.
19-08-2026
eYantra Ventures Limited has published a newspaper advertisement in Form NCLT 3A regarding its Scheme of Arrangement with its wholly owned subsidiary Prismberry Technologies Private Limited, following an order from the NCLT Hyderabad Bench II dated August 14, 2026. The advertisement was published on August 19, 2026, in Financial Express (English) and Prajasakti (Regional newspaper). No financial figures or performance metrics are disclosed in this filing.
- · The NCLT order was passed on August 14, 2026, by the Hyderabad Bench II.
- · The advertisement was published in Financial Express (English) and Prajasakti (Regional newspaper) on August 19, 2026.
- · The scheme involves Prismberry Technologies Private Limited (Wholly Owned Subsidiary/Transferor Company) merging with eYantra Ventures Limited (Holding Company/Transferee Company).
- · The filing references prior intimations dated May 25, 2026, and July 15, 2026.
19-08-2026
Cipla Limited announced that the National Company Law Tribunal (NCLT), Mumbai Bench, has approved the Scheme of Amalgamation of its wholly-owned subsidiary, Inzpera Healthsciences Limited, with Cipla Limited. The scheme, effective from April 1, 2026, aims to consolidate operations, achieve cost savings, and improve organizational efficiency. Since Inzpera is a wholly-owned subsidiary, no new shares will be issued, and the rights of Cipla's creditors are not expected to be adversely affected.
- · The NCLT order was pronounced on August 18, 2026, and the appointed date for the scheme is April 1, 2026.
- · Inzpera Healthsciences Limited has 7 equity shareholders and 1 preference shareholder, all of whom have provided consent, and the company has no secured creditors.
- · Cipla Limited has 7,567 unsecured creditors aggregating to ₹2,204.85 crore as of March 31, 2026.
- · The promoter and promoter group hold 29.21% of Cipla's paid-up equity share capital, while public shareholders hold 70.79%.
- · The scheme is expected to result in cost savings through rationalization, standardization, and elimination of duplication, as well as reduction in compliance costs.
19-08-2026
ARGENX SE is proceeding with its acquisition of Forte Biosciences, Inc. through its subsidiary Avena Merger Sub Inc. at $77.00 per share in cash. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on August 18, 2026, satisfying the HSR clearance condition. The tender offer remains subject to other conditions outlined in the Offer to Purchase.
- · Filing is an amendment to the Schedule TO, originally filed on August 6, 2026.
- · The HSR Act waiting period expired at 11:59 p.m. Eastern Time on August 18, 2026, clearing the antitrust condition.
- · The tender offer is a third-party offer subject to Rule 14d-1.
- · Offer price remains at $77.00 per share, net to the seller in cash, without interest.
19-08-2026
Zicom Electronic Security Systems Ltd (in CIRP) filed its audited standalone financial statements for FY 2022-23 on 19 August 2026, nearly 40 months after the year-end. The filing is a mandatory regulatory disclosure under the Insolvency and Bankruptcy Code and SEBI LODR. The auditor issued an adverse opinion due to multiple material discrepancies including undetermined impacts on tangible assets, inventories, investments, and other financial assets. The filing highlights ongoing operational challenges under the insolvency process, including non-cooperation by the erstwhile Resolution Professional and key managerial resignations.
- · CIRP initiated by NCLT Mumbai Bench on July 29, 2022.
- · Current RP Chirag R. Shah took over from erstwhile RP on September 4, 2025.
- · Auditor issued an adverse opinion for FY 2022-23 standalone financial statements.
- · Physical verification discrepancies in tangible assets and inventories not accounted for per Ind-AS 10 and Ind-AS 2.
- · No detailed bifurcation or supporting documents for investments in subsidiaries/joint ventures/associates (Note 7).
- · Other non-current financial asset balances subject to confirmation and reconciliation — impact currently unascertainable (Note 9).
- · Company's CFO resigned on March 15, 2021, and Company Secretary on February 28, 2022.
- · Erstwhile RP did not sign financial statements for FY 2022-23, contributing to delays.
- · Previous audit firm (SMPP & Co.) was discontinued by the current RP.
- · Financial statements signed solely for compliance, with the RP disclaiming personal liability per Section 233 of the Code.
19-08-2026
Kiri Industries Limited has incorporated a wholly owned subsidiary, Kiri Capital (IFSC) Private Limited, on August 19, 2026, with an issued share capital of INR 2,00,00,000 (20,00,000 equity shares of INR 10 each). The subsidiary is yet to commence business operations and will focus on treasury management and holding the company's overseas subsidiaries. No financial performance data is available as the entity is newly incorporated.
- · The subsidiary is incorporated under the IFSC (International Financial Services Centre) framework.
- · The subsidiary is a related party of Kiri Industries Limited as a wholly owned subsidiary.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration was cash, for 100% shareholding.
19-08-2026
SEBI has initiated adjudication proceedings against Mr. Bhavik Indravadan Shah and others for alleged front-running activities. The order was issued on August 19, 2026, under the enforcement wing of SEBI. This regulatory action indicates potential penalties or sanctions against the named individuals.
- · The filing is an adjudication order from SEBI's Office of Adjudication (AO).
- · The matter involves front-running activities, a form of market manipulation.
- · No specific financial penalties or amounts are mentioned in the filing.
19-08-2026
Unitech International Ltd disclosed the outcome of the 12th Meeting of the Committee of Creditors (CoC) held on July 8, 2026, under the Corporate Insolvency Resolution Process (CIRP). All five agenda items—including ratification of CIRP expenses, approval of professional fees for an accountant, appointment of legal counsel, appointment of a PCS firm for secretarial compliances, and appointment of a statutory auditor—were approved by the CoC. The filing provides no financial figures or performance metrics, reflecting the company's ongoing insolvency status.
- · The 12th CoC meeting was held on July 8, 2026, via video conferencing.
- · All five agenda items (B1 to B5) were approved by the Committee of Creditors.
- · Agenda items included ratification of CIRP expenses, approval of professional fees for an accountant, appointment of legal counsel, appointment of a PCS firm, and appointment of a statutory auditor.
- · The company is under CIRP, with Mr. Nitin Narang serving as Resolution Professional (IBBI Registration No. IBBI/IPA-002/IP-N00828/2019-2020/12629).
19-08-2026
SEBI has issued an Adjudication Order against Cube Trafin Private Limited in connection with the manipulation of illiquid stock options at the BSE. The order was published on August 19, 2026, signaling a regulatory enforcement action by the securities market regulator against the company.
- · The adjudication is in the matter of illiquid stock options trading at BSE.
- · The order was issued by SEBI's Adjudication Officer (AO) under the enforcement wing.
19-08-2026
Uday Narang has launched an open offer to acquire up to 12,22,000 (12.22 Lakh) fully paid-up equity shares of Pasupati Fincap Ltd at ₹12 per share, representing 26% of the voting share capital, for a total consideration of approximately ₹1.47 Cr. The offer is triggered by a Share Purchase Agreement dated August 5, 2026, and is not conditional on a minimum acceptance level; however, if fully accepted, the Acquirer's shareholding could rise to 37.55%. The tendering period runs from September 29 to October 13, 2026, with payment completion by October 28, 2026.
- · The open offer is made under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011.
- · The underlying transaction does not itself trigger the 25% threshold, but the offer could take the Acquirer's holding to 37.55%.
- · No competing offer exists as of the Draft Letter of Offer date.
- · The Identified Date for determining shareholders to receive the Letter of Offer is September 15, 2026.
- · Shareholders cannot withdraw tendered shares during the tendering period; a lien will be marked on them.
- · Non-resident shareholders (including NRIs, FPIs, OCBs) must obtain and submit requisite approvals (e.g., RBI) to tender shares.
- · In case of delay in payment, interest at 10% per annum may be payable by the Acquirer if the delay is attributable to the Acquirer.
- · The Acquirer may withdraw the offer only under specific conditions per Regulation 23(1) of SEBI (SAST) Regulations.
19-08-2026
Shraddha Prime Projects Ltd. approved the acquisition of 91% of Atharva Ventures Private Limited for ₹91,000 and 100% of Shraddha Life Spaces Private Limited for ₹10,36,98,200 (₹10.37 Cr), making them a subsidiary and wholly owned subsidiary respectively. Both target entities have zero turnover for the past three fiscal years, and the SLSPL acquisition is a related-party transaction. The acquisitions aim to expand the company's real estate portfolio.
- · Both target entities have zero turnover for FY 2022-23, FY 2023-24, and FY 2024-25.
- · The acquisition of Shraddha Life Spaces Private Limited is a related-party transaction; the promoter has an interest in SLSPL and the transaction is at arm's length.
- · The acquisition of Atharva Ventures Private Limited is not a related-party transaction.
- · Completion of both acquisitions is expected on or before August 20, 2026.
- · Consideration is in cash, based on valuation reports: ₹10 per share for AVPL and ₹11.02 per share for SLSPL.
19-08-2026
Torrent Power Limited announced the incorporation of two new step-down subsidiaries, Torrent Urja 50 Private Limited and Torrent Urja 51 Private Limited, on August 19, 2026. These wholly owned subsidiaries of Torrent Green Energy Private Limited (TGEPL) are focused on renewable energy, including hydrogen and power generation. The total investment in these SPVs is minimal at ₹5,00,000 each, with no financial impact on revenue or profitability disclosed, and no performance comparisons are available.
- · The SPVs were incorporated on August 19, 2026, with TGEPL holding 100% equity.
- · No governmental or regulatory approvals were required for incorporation.
- · Consideration was in cash, with each SPV subscribed at ₹5,00,000.
- · The incorporation is part of Torrent's expansion into hydrogen and renewable energy.
19-08-2026
3i Infotech Limited disclosed that a preliminary inquiry by the Economic Offence Wing, Navi Mumbai Police Commissionerate, concerning its complaint filed on February 3, 2026, found that the matter appears to be civil in nature. The complaint involves more than ₹128 Crore plus interest and damages as determined by relevant legal authorities; the financial impact remains unascertained, and the Company is obtaining legal opinion on its next course of action.
- · The original complaint was filed with the Additional Commissioner of Police, Economic Offence Wing, Navi Mumbai Police Commissionerate, on February 3, 2026.
- · The Economic Offence Wing letter was dated August 13, 2026, and the disclosure was filed on August 19, 2026.
- · The Company stated that the disclosure was disseminated with a delay because the letter was received in Marathi and required translation into English.
- · The actual impact of the matter on the listed entity and its financials is yet to be ascertained.
19-08-2026
Brigade Enterprises Limited has acquired 100% of the equity shares of Celebrations Private Limited, a step-down subsidiary, for a cash consideration of ₹30,00,000 (₹30 Lakh) at ₹10 per share. The acquisition, completed on August 19, 2026, makes Celebrations Private Limited a wholly owned subsidiary of Brigade Enterprises. The target entity has no turnover for the last three financial years and is not yet operational, so the transaction is a restructuring move with no immediate revenue impact.
- · The acquisition is a related party transaction between the company and its wholly owned subsidiary, done at arm's length.
- · Celebrations Private Limited was incorporated on November 8, 2021, and has had nil turnover for the financial years 2023-24, 2024-25, and 2025-26.
- · The target entity is in the real estate development business and is not yet operational.
- · No governmental or regulatory approvals were required for the acquisition.
19-08-2026
Digilogic Systems Ltd has invested ₹4,00,000 (Rupees Four Lakhs) to subscribe to 40,000 equity shares of ₹10 each in its newly incorporated subsidiary, Abhedhya Systems Private Limited, as an initial subscription. This follows a prior intimation dated May 27, 2026, and is disclosed under Regulation 30 of SEBI LODR. The investment is relatively small and represents a routine corporate structuring step with no immediate financial impact on the parent company.
- · Face value of each equity share subscribed is ₹10.
- · The investment was made at around 4:30 PM on August 19, 2026.
- · This is a follow-up to an earlier intimation dated May 27, 2026.
19-08-2026
19-08-2026
Texmaco Rail & Engineering Ltd invested ₹6,88,00,000 (₹6.88 Cr) in its subsidiary Texmaco Defence Technologies Ltd (TDTL) by subscribing to 6,88,000 equity shares at ₹100 each (₹10 face value + ₹90 premium). Concurrently, VAGUS DEF TECH & AEROSPACE FUND-1 acquired a 30% stake in TDTL at the same valuation, reducing Texmaco's holding from 100% to 70% and changing TDTL from a wholly-owned subsidiary to a subsidiary. The investment aims to expand Texmaco's footprint in the defence industry, though TDTL has reported nil revenue for the past three years and only ₹0.01 Cr total income as of March 2026.
- · TDTL was originally incorporated as 'Texmaco Rail Electrification Limited' on 26th February 2020 and renamed to 'Texmaco Defence Technologies Limited' effective 28th April 2026.
- · TDTL has reported nil revenue for the last three financial years and only ₹0.01 Cr total income as of 31st March 2026.
- · The transaction is not a related party transaction and does not require any governmental or regulatory approvals.
- · The investment is a cash transaction, not a share swap.
19-08-2026
Refex Renewables & Infrastructure Limited announced the withdrawal of the corporate insolvency resolution process (CIRP) against its step-down subsidiary Sherisha Solar LLP following a settlement with SILRES Energy Solutions Private Limited. The Hon'ble NCLT, Chennai Bench, vide order dated August 17, 2026, disposed of all related petitions, including the Section 7 IBC petition, the Section 65 application, and the oppression & mismanagement petition under Sections 241 & 242 of the Companies Act. This closure of disputes removes a significant legal overhang on the subsidiary, but the filing does not disclose any financial terms of the settlement or the impact on the company's financials.
- · The settlement was formalized through a Binding Memorandum of Understanding dated August 7, 2026, and definitive agreements executed on August 14, 2026.
- · The NCLT order was received by the company on August 19, 2026.
- · The withdrawal covers three separate proceedings: CP/IB/338(CHE)/2025 (Section 7 IBC), CP/(CA)/129(CHE)/2025 (Sections 241 & 242), and a Section 65 IBC application.
- · No financial details of the settlement or any consideration paid/received were disclosed.
19-08-2026
Artius II Acquisition Inc. (AACBU) filed a Form 25-NSE with the SEC on August 19, 2026, to delist its securities (Class A Ordinary Share, Right, Unit) from the Nasdaq Stock Market LLC. The delisting is effective as of the filing date under SEC Rule 17 CFR 240.12d2-2(a)(1). This action typically indicates the company is winding down or liquidating, as is common for blank-check companies that have not completed a business combination within their allotted timeframe.
- · The delisting is effective August 19, 2026.
- · The filing cites SEC Rule 17 CFR 240.12d2-2(a)(1) as the basis for delisting.
- · The company is classified as a blank check company (SIC 6770).
- · The delisting was filed by Nasdaq Stock Market LLC on behalf of the company.
19-08-2026
Oceanhawk Acquisition Corp. (OHAC) filed an 8-K on August 19, 2026, to adopt a formal Nominating and Corporate Governance Committee Charter. The charter outlines the committee's purpose, organization, meeting requirements, and authority, including director candidate identification, corporate governance oversight, and CEO succession planning. The filing is a routine governance update with no financial impact or material business changes.
- · Committee must consist of at least two directors, all meeting independence requirements within one year of listing.
- · Committee shall meet at least twice annually unless fewer meetings are determined.
- · Committee has sole authority to retain and terminate search firms and advisors for director candidates.
19-08-2026
Futurewave Capital Solutions Ltd and its sole director Daniel M. McCabe filed a Schedule 13D disclosing beneficial ownership of 3,955,625 ordinary shares (30.8%) of Futurewave Acquisition Corp, a blank-check SPAC. The shares were acquired through founder shares (3,700,125 for $25,000) and private placement units (255,500 for $2,555,000), with the sponsor paying an aggregate of $2,580,000. The filing details standard SPAC lock-up and voting agreements but does not indicate any imminent business combination or material change in strategy.
- · HBM Group, Inc. owns 17.83% of the Sponsor, and Luminark Holdings LLC owns 10% of the Sponsor.
- · The Founder Shares are subject to a 180-day lock-up from the completion of the Initial Business Combination; Private Units are locked up for 30 days post-combination.
- · The Sponsor and insiders agreed to vote in favor of a business combination, not to redeem shares, and to waive liquidation rights on Founder and Private Shares.
- · No transactions in Ordinary Shares occurred in the past 60 days except the June 26, 2026 Private Unit purchase.
19-08-2026
Viking Acquisition Corp. II, a blank-check company, issued a $514,080 promissory note to its sponsor, Viking Acquisition Sponsor II, LLC, on August 19, 2026. The non-interest-bearing note is due upon the earlier of the company's initial business combination or its winding up, and the sponsor may convert the principal into units of the post-merger entity at $10.00 per unit. This filing signals progress toward a merger target, but the company remains a pre-revenue SPAC with no operating performance to report.
- · The note carries zero interest and is unsecured.
- · Conversion is optional for the sponsor and limited to the post-business combination entity's units.
- · The sponsor has waived any claim against the SPAC's trust account, with repayment coming only from trust proceeds released upon a business combination.
- · The note is governed by New York law and contains standard default and remedy provisions.
19-08-2026
OceanLight Capital Sponsor Ltd. disclosed ownership of 5,144,750 ordinary shares (33.53%) of OceanLight Acquisition Corp in a Schedule 13D filing on August 19, 2026, following the SPAC's IPO on August 10, 2026. The Sponsor acquired 4,933,500 founder shares for $25,000 and 211,250 private placement units for $10.00 per unit. Up to 643,500 founder shares remain subject to forfeiture depending on underwriters' over-allotment exercise, and the sponsor has agreed to vote in favor of an initial business combination and waive certain redemption rights, but no target business combination has been announced yet.
- · The filing is a Schedule 13D (not a 13G), indicating active intent to influence or control the issuer.
- · HBM Group, Inc. owns 17.63% of the Sponsor, and Luminark Holdings LLC owns 10%.
- · The Sponsor's founder shares are subject to a 180-day lock-up following a business combination, and private units are locked for 30 days post-combination.
- · The Sponsor has waived redemption rights and rights to liquidating distributions from the trust account with respect to founder shares if no business combination is completed within the specified period.
- · The underwriters' over-allotment option has not been exercised as of the filing date.
- · No transactions in ordinary shares by the Sponsor occurred during the 60 days prior to the filing.
19-08-2026
Pelican II Capital Solutions Ltd filed a Schedule 13D disclosing beneficial ownership of 3,186,500 ordinary shares (26.36%) of Pelican Acquisition II Corp as of July 27, 2026. The sponsor acquired 2,875,000 founder shares for $25,000 and 311,500 private placement units at $10.00 per unit in connection with the issuer's IPO. The filing outlines lock-up, voting, and waiver agreements related to the blank-check company's initial business combination, but no business combination target has been announced.
- · The sponsor has sole voting and dispositive power over all 3,186,500 ordinary shares.
- · The sponsor agreed to vote its shares in favor of any initial business combination, waive redemption rights, and waive liquidation distributions if no business combination is completed within 21 months of the IPO.
- · No transactions in the issuer's ordinary shares were effected by the reporting person during the 60 days preceding the filing date.
- · The issuer is a blank check company formed for the purpose of effecting a merger or similar business combination.
19-08-2026
Xos, Inc. received a delisting notice from Nasdaq Stock Market LLC on August 19, 2026, for its warrants expiring August 20, 2026, under SEC Rule 12d2-2(a)(2). The delisting is effective as of the filing date, and the warrants will cease trading on Nasdaq.
- · Delisting is based on SEC Rule 17 CFR 240.12d2-2(a)(2).
- · The filing was made by Nasdaq Stock Market LLC, not by Xos, Inc.
- · The delisting applies specifically to the warrants (ticker XOSWW), not the common stock.
- · The warrants were set to expire on August 20, 2026, the day after the filing date.
19-08-2026
Karman Line Acquisition Corp. (XTER) announced the pricing of its $200 million initial public offering on August 17, 2026, consisting of 20,000,000 units at $10.00 per unit, expected to close on August 19, 2026. The SPAC intends to focus on business combinations in the aerospace and defense sectors, including space-based infrastructure. The offering targets a specific sector for acquisition but carries forward-looking uncertainties regarding completion of any business combination.
- · Units are expected to begin trading on Nasdaq under ticker 'XTERU' on August 18, 2026.
- · The offering is expected to close on August 19, 2026.
- · Underwriters have a 45-day option to purchase up to 3,000,000 additional units to cover over-allotments.
- · The registration statement was declared effective by the SEC on August 17, 2026.
- · The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
- · The Company intends to focus on sectors aligned with space-based infrastructure, specifically aerospace and defense.
19-08-2026
Genpact Limited filed an S-4 registration statement with the SEC on August 19, 2026, proposing to change its jurisdiction of incorporation from Bermuda to Delaware (the 'Domestication'). The Domestication, expected to be effective on or around March 1, 2027, requires shareholder approval at a special general meeting. The board unanimously recommends approval, and the company's NYSE ticker symbol 'G' will remain unchanged. No financial results or performance metrics are disclosed in this filing.
- · The Domestication will be effected under Section 388 of the General Corporation Law of the State of Delaware and Sections 132G and 132H of the Companies Act 1981 of Bermuda.
- · Each existing common share (par value $0.01) will convert automatically into one share of common stock (par value $0.01) of the new Delaware corporation.
- · The company will remain named 'Genpact Limited' after the Domestication.
- · Shareholders will also vote on an adjournment proposal to allow further solicitation if the Domestication is not initially approved.
- · The special general meeting will be held at 521 Fifth Avenue, 14th Floor, New York, NY 10175.
19-08-2026
OSR Health, Inc. received a Staff Determination from Nasdaq on August 19, 2026, notifying the company that its common stock (OSRH) and warrants (OSRHW) will be delisted from the Nasdaq Capital Market due to failure to maintain a minimum closing bid price of $1.00 per share. Trading will be suspended at the opening of business on August 26, 2026. The company intends to request a hearing before a Nasdaq Hearings Panel to appeal the determination, but a timely hearing request will not stay the trading suspension because the company had already used a second 180-day compliance period. While the company highlights extraordinary trading volume on August 17 and 18 (370 million and 145 million shares, respectively) and an intraday high of $0.84 on August 18, it remains non-compliant and faces a high risk of permanent delisting.
- · The company was originally notified of non-compliance on September 5, 2025, and received an initial 180-day compliance period through March 4, 2026, followed by a second 180-day period through August 31, 2026.
- · Because the company used the second 180-day compliance period, a timely hearing request will not stay the trading suspension scheduled for August 26, 2026.
- · The company's public float is approximately 18.5 million shares, meaning the market traded the entire float more than twenty times over on August 17.
- · The share price reached an intraday high of $0.84 on August 18, sixteen cents below the $1.00 compliance threshold.
- · There can be no assurance that the Panel will grant the company's request for continued listing or reinstatement of trading.
19-08-2026
DT Cloud Star Acquisition Corporation (DTSQU) filed an 8-K on August 19, 2026, announcing a change in its principal executive office address to 25 Christopher Columbus Dr Apt 4411, Jersey City, NJ 07302, effective August 17, 2026. The filing contains no financial data, merger updates, or other material operational changes.
- · The company is an emerging growth company as defined under SEC rules.
- · The company's securities (Units, Ordinary Shares, Rights) are listed on The Nasdaq Stock Market LLC under symbols DTSQU, DTSQ, and DTSQR respectively.
- · The address change was effective August 17, 2026, two days before the filing date.
19-08-2026
Zerostack Corp. (FLGC) announced a definitive transaction to receive US$1.0 billion of Memecore ($M) tokens from Puple AI Inc. and Blockcat Pte. Ltd. in exchange for 3.5 million common shares and pre-funded warrants for up to 36.2 million additional shares at US$25.19 per share—a premium of more than 12x the recent market price. The contributed tokens (925,925,926 $M) were valued at the prevailing market price of US$1.08 per token. While the deal significantly expands Zerostack's strategic position in decentralized AI and the Memecore ecosystem, the warrants require shareholder approval under Nasdaq rules and are subject to a lock-up of up to ten years, and the company also operates a pharmaceutical distribution business through Phatebo GmbH, which is not mentioned in the transaction context.
- · The warrants require shareholder approval under Nasdaq Listing Rule 5635 before shares can be issued.
- · Shares issuable upon warrant exercise are subject to a lock-up of up to ten years following closing.
- · Zerostack also operates a global pharmaceutical distribution business through its wholly owned subsidiary, Phatebo GmbH.
- · The transaction was announced on August 19, 2026, via an 8-K filing.
19-08-2026
Mereo BioPharma Group Plc has received a second notice from Nasdaq indicating it remains non-compliant with the $1.00 minimum bid price requirement but has been granted an additional 180-day period, until February 16, 2027, to regain compliance. If the closing bid price of its ADSs does not close at least $1.00 for 10 consecutive business days by that date, Nasdaq will initiate delisting proceedings. The company has no immediate effect on its listing and may consider options to address the bid price deficiency.
- · First notice of non-compliance received on February 17, 2026.
- · Second compliance period ends on February 16, 2027.
- · If compliance is not regained, the company may appeal the delisting determination to a Nasdaq Hearings Panel.
- · The filing includes forward-looking language cautioning about risks including ability to maintain Nasdaq listing.
19-08-2026
Ocean Capital Acquisition Corp announced the resignation of two directors, Hin Wing (Simon) Wong and Hiu Man (Elliott) Cheng, effective August 14, 2026, with no disagreements cited. The board subsequently appointed two independent directors: Wei-Chieh Hao (effective August 16) and Richard T. Betts (effective August 18), who bring extensive experience in asset management and sustainability, respectively. The changes appear routine and non-disruptive, with no financial metrics or performance data disclosed.
- · Mr. Hao has over 25 years in asset management and financial services, currently Executive Director and Responsible Officer at Meyer Capital Group Limited since 2017.
- · Mr. Betts has over 20 years in financial auditing, sustainability, and climate change; he is a Fellow Chartered Accountant (ICAEW) and holds an MPhil in Earth Sciences from Cambridge.
- · Both new directors are independent and have no family relationships or material interests requiring disclosure under Item 404(a).
- · The resignations were not due to any disagreement with the company's operations, policies, or practices.
19-08-2026
Earth Science Tech, Inc. (ETST) acquired Zoolzy LLC, a Florida-based wholesale distributor of APIs and finished FDA-approved prescription products, to drive margin expansion and enter the veterinary market. The acquisition is expected to be immediately accretive by internalizing wholesale API procurement for ETST's compounding pharmacies and providing access to novel ingredients. No financial terms of the deal were disclosed, and no prior-period comparisons are available.
- · Zoolzy is a wholesale distributor of APIs and finished FDA-approved prescription products.
- · The acquisition provides ETST with procurement access to common veterinary medications.
- · ETST plans to formulate unique, flavored, and easy-to-administer veterinary therapeutics.
- · The veterinary expansion is spearheaded by key members of ETST's management team with expertise in the exotic wildlife space.
- · Zoolzy operates from a 3,684-square-foot facility in Doral, Florida.
19-08-2026
Aetos Distressed Investment Strategies Fund, LLC filed a final amendment to its tender offer statement, reporting that it accepted $236,552.00 of limited liability company interests tendered by members, well below the $2,000,000 maximum. The offer expired on June 30, 2026, and payment was made on July 30, 2026. The low acceptance amount indicates limited member participation relative to the authorized maximum.
- · The tender offer was an issuer tender offer subject to Rule 13e-4.
- · Members had until 12:00 midnight New York time on June 30, 2026 to tender interests.
- · Withdrawal rights were available until the offer expired and thereafter if interests had not been accepted.
- · Net asset value for the tendered interests was calculated as of June 30, 2026.
- · Payment was made on July 30, 2026.
19-08-2026
Aetos Multi-Strategy Arbitrage Fund LLC completed a tender offer to repurchase up to $2,000,000 of its limited liability company interests. The offer expired on June 30, 2026, with members tendering $730,082.63 in aggregate interests, which were accepted and paid on July 30, 2026. The actual repurchase amount was significantly below the maximum $2,000,000 target, indicating lower-than-expected member participation.
- · The tender offer was an issuer tender offer under Rule 13e-4.
- · Members could tender interests at net asset value, calculated as of June 30, 2026.
- · Tenders were due by 12:00 midnight New York time on June 30, 2026, with withdrawal rights until the same deadline.
- · Payment for accepted interests was made on July 30, 2026.
- · The filing is a final amendment reporting the results of the offer.
19-08-2026
Aetos Long/Short Strategies Fund, LLC filed a final amendment to its tender offer statement, reporting that it accepted tenders of limited liability company interests totaling $791,063.38, well below the maximum $2,000,000 offered. The offer expired on June 30, 2026, and payment was made on July 30, 2026. The low participation indicates limited member interest in the buyback.
- · Tender offer expired on June 30, 2026, at 12:00 midnight New York time.
- · Payment for accepted tenders was made on July 30, 2026.
- · The offer was an issuer tender offer subject to Rule 13e-4.
- · The filing is a final amendment reporting results of the tender offer.
19-08-2026
John Hancock Comvest Private Income Fund has launched an issuer tender offer to repurchase up to 5% of its outstanding Class I Shares (951,485.51 shares) as of June 30, 2026. The purchase price will be the net asset value as of the September 30, 2026 valuation date, with payment via a non-interest-bearing promissory note. The offer expires on September 18, 2026, and no officers, trustees, or affiliates intend to tender shares.
- · Only Class I Shares are outstanding (19,029,710.15 shares); no Class S, D, or F shares are outstanding.
- · The offer is scheduled to expire on September 18, 2026, unless extended.
- · Payment for accepted shares will be made via a non-interest-bearing, non-transferable promissory note held by the transfer agent.
- · The Fund expects to fund the purchase from cash flow, asset sales, borrowings, return of capital, or offering proceeds.
- · No officers, trustees, or affiliates intend to tender shares in the offer.
- · The Adviser expects to recommend quarterly tender offers, but the Fund is not required to conduct them.
19-08-2026
iSHARES TRUST filed a Form 25-NSE with the SEC on August 19, 2026, notifying the removal from listing and registration of its iShares ESG Aware 60/40 Balanced Allocation ETF (ticker: EAOR) on the Cboe BZX Exchange. The delisting was voluntary, with trading suspended on August 13, 2026, and the fund liquidated on August 17, 2026; the delisting becomes effective August 31, 2026. No financial performance data is provided in this filing.
- · The delisting is voluntary under SEC Rule 17 CFR 240.12d2-2(a)(2).
- · Suspension of trading occurred on August 13, 2026.
- · Liquidation (redemption) of the fund took place on August 17, 2026.
- · Delisting effective date is August 31, 2026.
Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →August 20, 2026
US Pre-Market SEC Filings Roundup — August 20, 2026
US Pre-Market SEC Filings Roundup
August 20, 2026
USA Corporate Events Calendar — August 20, 2026
USA Corporate Events Calendar
August 20, 2026
US Executive Officer Management Changes SEC — August 20, 2026
US Executive Officer Management Changes SEC
August 20, 2026
US IPO Pipeline SEC S-1 Filings — August 20, 2026
US IPO Pipeline SEC S-1 Filings